Again, IMU announced they plan to commence Ph2 clinical trial for PD1-Vaxx this year and like I told you then, I prefer they spend their resource and fund on the clinical trials for VAXINIA, OASIS and Azer-Cel as these are the IP with FDA IND, Fast Track designation and ODD which BP are attracted.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $112.0M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.4¢ | $14.78K | 1.028M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 12277644 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 11198410 | 40 |
View Market Depth
| Last trade - 10.39am 17/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |